2674 related articles for article (PubMed ID: 28579299)
1. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
[TBL] [Abstract][Full Text] [Related]
3. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
[TBL] [Abstract][Full Text] [Related]
4. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
[TBL] [Abstract][Full Text] [Related]
5. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice.
Naznin F; Sakoda H; Okada T; Tsubouchi H; Waise TM; Arakawa K; Nakazato M
Eur J Pharmacol; 2017 Jan; 794():37-44. PubMed ID: 27876617
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
[TBL] [Abstract][Full Text] [Related]
7. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization.
Xu L; Ota T
Adipocyte; 2018; 7(2):121-128. PubMed ID: 29376471
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
10. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
11. SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats.
Yokono M; Takasu T; Hayashizaki Y; Mitsuoka K; Kihara R; Muramatsu Y; Miyoshi S; Tahara A; Kurosaki E; Li Q; Tomiyama H; Sasamata M; Shibasaki M; Uchiyama Y
Eur J Pharmacol; 2014 Mar; 727():66-74. PubMed ID: 24486393
[TBL] [Abstract][Full Text] [Related]
12. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
Kwon EY; Choi MS
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
[TBL] [Abstract][Full Text] [Related]
13. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
[TBL] [Abstract][Full Text] [Related]
14. The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin.
Kern M; Klöting N; Mark M; Mayoux E; Klein T; Blüher M
Metabolism; 2016 Feb; 65(2):114-23. PubMed ID: 26773934
[TBL] [Abstract][Full Text] [Related]
15. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.
Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T
Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760
[TBL] [Abstract][Full Text] [Related]
16. Berberine, a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice Fed a High-Fat Diet.
Lin J; Cai Q; Liang B; Wu L; Zhuang Y; He Y; Lin W
Med Sci Monit; 2019 Jan; 25():87-97. PubMed ID: 30606998
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
[TBL] [Abstract][Full Text] [Related]
18. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues.
Dong J; Dong Y; Dong Y; Chen F; Mitch WE; Zhang L
Int J Obes (Lond); 2016 Mar; 40(3):434-442. PubMed ID: 26435323
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
